Retatrutide vs Semax
A comprehensive, data-driven comparison of Retatrutide (LY3437943) and Semax. Compare efficacy, side effects, costs, FDA approval status, and clinical evidence to make an informed decision.
Side-by-Side Comparison
| Property | Retatrutide LY3437943 | Semax |
|---|---|---|
| FDA Status | Phase 3 (NDA expected late 2026) | Not submitted |
| Category | Weight Loss | Cognitive Enhancement |
| Primary Use | Obesity and weight management | Cognitive enhancement and neuroprotection |
| Weight Loss % | 28.7% | N/A |
| Monthly Cost | $1,200 - $1,500/mo | $45 - $90/mo |
| Administration | Subcutaneous injection | Nasal spray |
| Typical Dose | 12mg weekly (dose escalated from 2mg) | 2-3 drops per nostril 2-3x daily |
| Frequency | Weekly | Daily |
| Mechanism | Triple agonist targeting GIP, GLP-1, and glucagon receptors to enhance insulin secretion, reduce appetite, and increase energy expenditure | Synthetic ACTH analog that enhances BDNF production, improves cerebral circulation, and protects neurons |
| Common Side Effects |
|
|
| Serious Side Effects |
|
|
| Evidence Quality | High | Moderate |
| Clinical Trial Phase | Phase 3 | N/A |
Key Differences
- 1Retatrutide has clinical weight loss data (28.7%), while Semax is not primarily indicated for weight loss.
- 2Semax is generally more affordable ($45 - $90/mo) compared to Retatrutide ($1,200 - $1,500/mo).
- 3Retatrutide is administered via subcutaneous injection, while Semax uses nasal spray.
- 4Retatrutide is dosed weekly, while Semax is daily.
- 5Retatrutide has high-quality evidence, while Semax has moderate-quality evidence.
- 6They belong to different categories: Retatrutide (Weight Loss) vs Semax (Cognitive Enhancement).
Which Is Better For...
Semax
More budget-friendly option with lower monthly costs
Retatrutide
More convenient dosing schedule (weekly)
Semax
Fewer commonly reported side effects
Retatrutide
Stronger clinical evidence base to support its use
Cost Comparison
| Peptide | Monthly Cost Range | FDA Status | Manufacturer |
|---|---|---|---|
| Retatrutide | $1,200 - $1,500/mo | Phase 3 (NDA expected late 2026) | Eli Lilly |
| Semax | $45 - $90/mo | Not submitted | Various research labs |
Prices are estimated monthly costs and may vary based on pharmacy, insurance coverage, and manufacturer assistance programs. Costs for non-FDA-approved peptides reflect research compound pricing.
Frequently Asked Questions
Retatrutide works via Triple agonist targeting GIP, GLP-1, and glucagon receptors to enhance insulin secretion,. Semax works via Synthetic ACTH analog that enhances BDNF production, improves cerebral circulation, and protects. They differ in FDA approval status, efficacy data, and cost.
Retatrutide has demonstrated 28.7% average weight loss in clinical trials. Semax is not primarily used for weight loss.
Retatrutide typically costs $1,200 - $1,500/mo, while Semax costs $45 - $90/mo. Prices may vary by pharmacy, insurance coverage, and manufacturer programs.
Retatrutide is not FDA-approved (Phase 3 (NDA expected late 2026)). Semax is not FDA-approved (Not submitted). FDA approval indicates the treatment has met rigorous safety and efficacy standards.
Common side effects of Retatrutide include Nausea, Diarrhea, Vomiting. Common side effects of Semax include Nasal irritation, Mild stimulation, Headache. Always consult a healthcare provider about potential side effects.
Switching between peptide therapies should only be done under the guidance of a qualified healthcare provider. They can evaluate your medical history, current response, and determine the safest transition protocol.
Learn More
Retatrutide is a novel triple-receptor agonist developed by Eli Lilly currently in Phase 3 clinical trials. It has demonstrated unprecedented weight loss results, with patients losing an average of 28...
View Full Retatrutide GuideSemax is a synthetic peptide analog of adrenocorticotropic hormone (ACTH) developed in Russia. It has been shown to increase brain-derived neurotrophic factor (BDNF), improve cerebral blood flow, and ...
View Full Semax GuideOther Popular Comparisons
Medical Disclaimer
The information provided on this page is for educational and informational purposes only and does not constitute medical advice. This comparison between Retatrutide and Semax should not be used as a substitute for professional medical guidance. Always consult a qualified healthcare provider before starting, stopping, or modifying any peptide therapy. Clinical data cited may be from ongoing trials and is subject to change. Individual results may vary significantly. PeptideVS does not endorse, recommend, or promote the use of any specific peptide for medical treatment.